| 摘要 |
<p>Novel compounds represented by formula (I): wherein Y, Z, X, W, R1, R2 and R3 are as defined herein, or pharmaceutically acceptable salts, hydrates or solvates thereof, are useful for the modulation of CCR5 chemokine receptor activity and the treatment or prevention of diseases associated therewith.</p> |
| 申请人 |
VIROCHEM PHARMA INC.;CHAN CHUN KONG, LAVAL;ZHANG, MING-QIANG;MOINET, CHRISTOPHE;PROULX, MELANIE;REDDY, THUMKUNTA, JAGADEESWAR;COURCHESNE, MARC |
发明人 |
CHAN CHUN KONG, LAVAL;ZHANG, MING-QIANG;MOINET, CHRISTOPHE;PROULX, MELANIE;REDDY, THUMKUNTA, JAGADEESWAR;COURCHESNE, MARC |
